IPXL Crosses Above Average Analyst Target
June 21, 2017 at 09:15 AM EDT
In recent trading, shares of Impax Laboratories Inc (IPXL) have crossed above the average analyst 12-month target price of $15.50, changing hands for $15.75/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..